FDA’s On­col­o­gy Cen­ter of Ex­cel­lence touts 2018 ac­com­plish­ments

Im­age: Richard Paz­dur. FDA via FLICKR

The FDA’s re­cent­ly cre­at­ed in­ter-cen­ter On­col­o­gy Cen­ter of Ex­cel­lence (OCE) on Mon­day re­leased its first-ever an­nu­al re­port tout­ing its ac­com­plish­ments in 2018.

OCE was launched in 2017 to speed the de­vel­op­ment and re­view of on­col­o­gy prod­ucts across the FDA’s three med­ical prod­uct cen­ters.

“In 2018, we es­tab­lished a core OCE man­age­ment team and con­tin­ued the work be­gun in 2017 of build­ing pro­grams and launch­ing ini­tia­tives to lever­age ex­per­tise across the FDA and oth­er fed­er­al health agen­cies, as well as acad­e­mia, com­mu­ni­ty prac­ti­tion­ers, and in­dus­try, to ad­vance the de­vel­op­ment and reg­u­la­tion of prod­ucts for peo­ple with can­cer,” writes OCE Di­rec­tor Richard Paz­dur.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER